IGC Pharma (IGC) Leases (2020 - 2025)
IGC Pharma (IGC) has disclosed Leases for 6 consecutive years, with $13000.0 as the latest value for Q3 2025.
- On a quarterly basis, Leases fell 91.93% to $13000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $13000.0, a 91.93% decrease, with the full-year FY2025 number at $98000.0, down 50.51% from a year prior.
- Leases was $13000.0 for Q3 2025 at IGC Pharma, down from $16000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $538000.0 in Q2 2021 to a low of $13000.0 in Q3 2025.
- A 5-year average of $292105.3 and a median of $295000.0 in 2023 define the central range for Leases.
- Peak YoY movement for Leases: fell 2.71% in 2021, then tumbled 91.93% in 2025.
- IGC Pharma's Leases stood at $482000.0 in 2021, then decreased by 25.93% to $357000.0 in 2022, then tumbled by 36.41% to $227000.0 in 2023, then plummeted by 43.17% to $129000.0 in 2024, then plummeted by 89.92% to $13000.0 in 2025.
- Per Business Quant, the three most recent readings for IGC's Leases are $13000.0 (Q3 2025), $16000.0 (Q2 2025), and $98000.0 (Q1 2025).